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Correction to:  Drug Safety  
https ://doi.org/10.1007/s4026 4-019-00797 -3
In the original publication of this article, the following cor-
rection should be noted in Table 5.
The 95% CI for serious infections in the Ustekinumab 
−MTX group under PsA should read 0.8–3.5 and not 
0.8–3.5.5.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution-NonCommercial 4.0 International License 
(http://creativecommons.org/licenses/by-nc/4.0/), which permits any 
noncommercial use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the 
source, provide a link to the Creative Commons license, and indicate 
if changes were made.  
The original article can be found online at https ://doi.org/10.1007/
s4026 4-019-00797 -3.
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